Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
- Peter Lynch
Why insider trading matters?
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. In addition, the company is developing combination of MGD009 and MGA012; MGC018, an antibody drug conjugate, which targets solid tumors expressing B7-H3; and MGD014, a DART molecule that targets envelope protein of human immunodeficiency virus infected cells and T cells. It has strategic collaborations with Incyte Corporation; Zai Lab Limited; and I-Mab Biopharma.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-06-16 | BIOTECH TARGET N V | 10%-Owner | Buy | 175,000 | $20.82 | $3,644,005 | No |
| 2021-03-22 | Bonvini Ezio | Sr VP, Research & CSO | Sell | 3,917 | $32.00 | $125,344 | No |
| 2020-12-29 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 500 | $24.10 | $12,050 | Yes |
| 2020-11-30 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 500 | $23.35 | $11,675 | Yes |
| 2020-10-28 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 1,500 | $20.69 | $31,035 | Yes |
| 2020-09-28 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 500 | $25.33 | $12,665 | Yes |
| 2020-09-18 | Bonvini Ezio | Sr VP, Research & CSO | Sell | 62,851 | $30.50 | $1,916,867 | No |
| 2020-09-09 | Galbraith Kenneth | Director | Sell | 20,773 | $27.11 | $563,156 | Yes |
| 2020-08-26 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 500 | $27.10 | $13,550 | Yes |
| 2020-08-20 | Spitznagel Thomas | Sr VP, BPD & Manufacturing | Sell | 7,500 | $26.87 | $201,525 | Yes |
| 2020-07-27 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 4,489 | $25.47 | $114,319 | Yes |
| 2020-05-26 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 500 | $26.59 | $13,295 | Yes |
| 2020-02-20 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 500 | $10.84 | $5,420 | Yes |
| 2019-02-06 | Peters Jeffrey Stuart | General Counsel | Sell | 68 | $30.00 | $2,040 | No |
| 2018-01-24 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 3,000 | $22.50 | $67,500 | Yes |
| 2018-01-24 | Risser Eric Blasius | Sr VP & Chief Business Officer | Sell | 3,000 | $22.50 | $67,500 | Yes |
| 2018-01-17 | Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Sell | 5,000 | $20.00 | $100,000 | Yes |
| 2017-06-05 | Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Sell | 5,000 | $20.00 | $100,000 | Yes |
| 2016-10-03 | Wigginton Jon Marc | Sr VP, Clinical Dev. & CMO | Sell | 10,000 | $29.34 | $293,400 | Yes |
| 2016-07-01 | Wigginton Jon Marc | Sr VP Clinical Dev & CMO | Sell | 5,000 | $27.22 | $136,100 | Yes |
| 2016-07-01 | Cilinski Lynn | VP, Controller and Treasurer | Sell | 8,922 | $27.22 | $242,857 | Yes |
| 2016-05-27 | Cilinski Lynn | VP, Controller and Treasurer | Sell | 5,000 | $25.00 | $125,000 | Yes |
| 2016-03-03 | Costa Paulo F | Director | Buy | 10,000 | $17.20 | $172,000 | No |
| 2016-01-04 | Wigginton Jon Marc | Sr VP, Clinical | Sell | 10,000 | $29.64 | $296,400 | Yes |
| 2015-11-23 | Cilinski Lynn | VP, Controller and Treasurer | Sell | 6,921 | $35.00 | $242,235 | Yes |
| 2015-10-15 | Bonvini Ezio | Senior VP, Research | Sell | 6,233 | $25.21 | $157,134 | No |
| 2015-10-01 | Wigginton Jon Marc | Sr VP, Clinical | Sell | 5,000 | $21.11 | $105,550 | Yes |
| 2015-07-10 | Bonvini Ezio | Senior VP, Research | Sell | 2,400 | $38.09 | $91,416 | Yes |
| 2015-06-24 | Bonvini Ezio | Senior VP, Research | Sell | 6,097 | $38.08 | $232,174 | Yes |
| 2015-06-15 | Bonvini Ezio | Senior VP, Research | Sell | 6,233 | $34.01 | $211,984 | Yes |
Insider Smart
Insider Smart